Clinical trial
Multicentre Dose Ranging Study for Once Daily GSK233705 in COPD
NCT00676052 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre Dose Ranging Study for Once Daily GSK233705 in COPD
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 16, 2008
- Completion date
- December 22, 2008
- Enrollment
- 576 (actual)
- Sites
- 88
Conditions
As the registry lists them; a condition with its own page is linked.